-
Science sub-published a new breakthrough! Blocking immunosuppressed neutrophils can inhibit brain metastasis!
Time of Update: 2020-06-26
, June 16, 2020 /PRNewswire/ -- Biovalley BIOON/-- Brain metastasis, which occurs in many cancers, is an ominous discovery that is still difficult to treat The treatment of these metastatic tumor
-
God drug metformin anti-cancer hammer! PNAS reveals the mechanism by which metformin inhibits KRAS mutation metastatic colorectal cancer!
Time of Update: 2020-06-26
, June 2020 / Biovalley BIOON /- Metastatic colorectal cancer (mCRC) patients with either Iliticon or Oshariplatin-based chemotherapy combined with anti-EGFR (epidermal growth factor receptor) medi
-
Brit J Cancer: Anti-Acid Drugs and Colorectal Cancer Risk
Time of Update: 2020-06-25
Although there are some reasonable biological mechanisms associated with the development of proton pump inhibitors (PPI) and H2 receptor antagonists (H2RAs) with colorectal tumors, their association
-
FDA approves PD-1 monoanti-Keytruda's second biomarker-based tumor indication
Time of Update: 2020-06-25
Merck announced that FDA approved its PD-1 monoantitic Keytruda (pembrolizumab) for the treatment of patients with high tumor mutation load (TMB-H) who cannot remove or metastatic solid tumors, wh
-
Lancet: Aspirin May Reduce Colon Cancer Risk in People With Lynch Syndrome
Time of Update: 2020-06-25
Lynch syndrome is associated with an increased risk of many tumors, especially endometrial cancer In 2011, researchers examined the long-term effects of daily aspirin use on tumor prevention in pe
-
Elderly women, left waist discomfort more than half a year, please diagnose!
Time of Update: 2020-06-25
Department of Urology patients, female, 71-year-old "Main complaint" left lumbar discomfort for more than half a year, aggravated January "current medical history" patients six months
-
EHA 2020: New anti-cancer peptide-drug conjugate Melflufen treatment of refractive multiple myeloma, Phase 2 HORIZON trial successful
Time of Update: 2020-06-25
At the 25th Meeting of the European Hematology Association, Oncopeptides announced the main results of the Phase 2 HORIZON study on the treatment of patients with recurrent refractive merilloma (RRM
-
National Nanoscience Center to realize the transformation of nanodrug results
Time of Update: 2020-06-25
Recently, the National Nanoscience Center (hereinafter referred to as the Nano-Center) held in Beijing, "injection of hydrochloric acid Ilithikang (nano) beam" technology transfer summary briefing C
-
Male, physical examination found the right lung occupaic lesions 21 days, please diagnose!
Time of Update: 2020-06-25
Department of Thoracic Surgery "Basic Information" patients, male, 56-year-old "Main complaint" body found right lung occupaic lesions 21 days "past history" self-confessed physical fi
-
New drug for acute myeloid leukemia (AML) ! FDA approves Pfizer Mylotarg: Treatment of 1 month, new diagnosis, CD33 positive pediatric patients!
Time of Update: 2020-06-25
, June 17, 2020 / BIOON/ -- The U.S Food and Drug Administration ( FDA ) has approved the expansion of the -targeted cancer drug Mylotarg (gemtuzumab ozogamicin) in patients with cd3-positive acu
-
Lancet Oncol: Increased risk of death from new coronary pneumonia in patients with chest tumours
Time of Update: 2020-06-25
Studies have shown that patients with COVID-19 with tumors have a high mortality rate, and researchers recently examined the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
-
JAMA Surg: Circulating exomer lncRNA-GC1 for early gastric cancer diagnosis
Time of Update: 2020-06-25
Gastric cancer (GC)-related long non-coding RNA1 (lncRNA-GC1) plays an important role in the development of stomach cancer, and researchers recently explored the value of cyclosisl exosome lncRNA-
-
NICE supports Roche's ALK inhibitor Rozlytrek to treat ROS1-positive non-small cell lung cancer patients
Time of Update: 2020-06-25
NICE UK has published a draft final guidelines to support the NHS's use of Roche's ALK inhibitor Rozlytinib for patients with advanced non-small cell lung cancer ( NSCLC ) who have not previously b
-
Guangzhou expert: high esophageal cancer can also be minimally invasive cure surgery
Time of Update: 2020-06-25
Southern Medical University, The Chinese and Western Medicine Association Hospital on the 11th, the hospital's thoracic surgery Director Dr Zhang Caiming recently led the team to successfully compl
-
Nature: Nature reveals how the body's 'steriliser' became an accomplice to cancer metastasis, promising to stop the spread of cancer
Time of Update: 2020-06-25
Neutrophils are immune cells that provide the body with the first line of defense against infection However, this line of defense is sometimes less "strong" because neutrophils also have the abi
-
JAMA: Large retrospective cohort study shows that middle-aged and older people with high blood sugar are more likely to develop pancreatic cancer
Time of Update: 2020-06-25
Introduction: Glycited hemoglobin (HbA 1c) is a gold indicator for patients with diabetes , while diabetics are twice as likely to develop pancreatic cancer as normal people If HbA 1c is tested,
-
NATURE: "One-in-one" CAR T can also reverse aging
Time of Update: 2020-06-25
Cell aging is characterized by stable cell cycle stops and secretion characteristics to regulate the tissue microenvironment Physiologically, aging, as a tumor inhibition mechanism, can prevent the
-
Zepzelca approved in U.S., second-line treatment for metastatic small cell lung cancer
Time of Update: 2020-06-25
Jazz Pharmaceuticals and its partner PharmaMar announced that FDA has approved Zepzelca (lurbinectin) for the treatment of metastatic small cell lung cancer (SCLC) in adult patients with disease p
-
The new drug Zepzelca (lurbinectin) for metastatic small cell lung cancer (SCLC) has been approved
Time of Update: 2020-06-25
The pharmaceutical company Jazz said that FDA approved Zepzelca (lurbinectin) for the treatment of metastatic small cell lung cancer (SCLC), an alkylification drug that binds to the remains of the
-
Diffuse hyperplout nephroblastoma 1 case
Time of Update: 2020-06-25
Children and boys, 11 months and 17 days Because of the discovery of painless abdominal swelling 1 week admission, no fever, blood urine and other discomfort Physical examination: generally good con